{"id":"nct:NCT04381936","kind":"trial","title":"Randomised Evaluation of COVID-19 Therapy","authors":["University of Oxford"],"author_count":1,"year":2020,"published":"2020-05-11","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT04381936","source_url":"https://clinicaltrials.gov/study/NCT04381936","archive_url":"https://space-kitty.com/papers/nct:NCT04381936","updated":"2026-04-21","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"RECOVERY is a randomised trial of treatments to prevent death in patients hospitalised with pneumonia. The treatments being investigated are: COVID-19: Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids, Azithromycin, Colchicine, IV Immunoglobulin (children only), Convalescent plasma, Casirivimab+Imdevimab, Tocilizumab, Aspirin, Baricitinib, Empagliflozin, Sotrovimab, Molnupiravir, Paxlovid or Anakinra (children only) Influenza: Baloxavir marboxil, Oseltamivir, Corticosteroids (dexamethasone) Community-acquired pneumonia: Corticosteroids (dexamethasone)","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pneumonia"],"details":{"acronym":"RECOVERY","status":"RECRUITING","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":70000,"sponsor":"University of Oxford","conditions":["Pneumonia"],"interventions":["DRUG: Lopinavir-Ritonavir","DRUG: Corticosteroid","DRUG: Hydroxychloroquine","DRUG: Azithromycin","BIOLOGICAL: Convalescent plasma","DRUG: Tocilizumab","BIOLOGICAL: Immunoglobulin","DRUG: Synthetic neutralising antibodies","DRUG: Aspirin","DRUG: Colchicine"],"start_date":"2020-03-19","start_date_type":"ACTUAL","primary_completion_date":"2028-09-30","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"infectious-disease-amr","name":"Infectious Disease, Vaccines & Antimicrobial Resistance","domain_slug":"medicine"}],"cited_in_dossiers":[]}